featured
Highly Enlightened: Bryan Gerber, CEO at Hara Supply

Published
4 months agoon

Find us in your favorite podcast app:
Spotify
SoundCloud
iTunes
Stitcher
In this episode of Highly Enlightened, host Jon Purow connects with Bryan Gerber, the founder and CEO of HARA Supply, a supplier of custom preroll cones and packaging. HARA Supply spans 15 facilities with over 4,000 personnel based in India, along with HQ office and warehouse located in Las Vegas, NV. They currently produce over a billion pre-rolled cones per year for some of the cannabis industry’s largest entities.
Gerber is also the founder and CEO of HARA Brands, a four-time inc. 5000 company, which includes: Hemper, the largest subscription business in the cannabis industry with more than 1 million boxes sold, as well as Hemper Tech and Goody Glass, providing high quality smoking accessories and related products.
Listen to the episode below or wherever you get your podcasts — you can find more episodes of Highly Enlightened on Buzzsprout.
Listen to the episode:
Episode sponsored by eBottles
This episode of Highly Enlightened is made possible by eBottles. If you’re in the cannabis business, you know that quality packaging isn’t just important—it’s essential. That’s where eBottles comes in. Whether you’re just starting out or scaling up, eBottles offers proprietary top-of-the-line packaging products built for cannabis. eBottles is a market leader for a good reason: they are experts in the field. Six patents, five warehouse locations around the country, a network of exceptional distributors. Get eBottles and Grow Boldly.
Read the Transcript:
Note: this transcript was automatically generated and may contain errors.
Jon Purow:
Welcome to an interview episode of Highly Enlightened, I’m your host, John Purow. Now, before we get to a very, very exciting interview, I want to note that any views I express are my own now as I always like to do, and most of the time it’s successful. I want to do a quick prayer to the video chat. Gods may. Our wifi connections be sturdy. All dogs and children, they’re around remain quiet and may Amazon Prime another time. Amen. Now I have the pleasure of introducing Brian Gerber, the CEO of HARA Supply, a major player here in the industry. And I just want to first say thank you for taking the time out of your busy schedule to join me for this joint endeavor, pun intended.
Bryan Gerber:
Thanks for having me on, John. I appreciate it. Looking forward to chatting about the industry today.
Jon Purow:
Yes. And for those unfamiliar, I do just want to note that Harris Supply is the largest manufacturer of cannabis cones and combustibles in the world. And you produce a hundred million plus cones monthly, which means that you produce over a billion per year. Which leads me to my first always incredibly serious question. Do you enjoy being able to say that you sell 1 billion items per year? Because that is an amazingly large round number. Is there any enjoyment that you get in being able to say it, and do you do it with accents or impersonations?
Bryan Gerber:
I reserve the doctor evil impersonation for my closest confidants, but no, it is pretty cool to say that we produce over a billion cones a year and products alike. I think a lot of people don’t realize the scale of millions, two billions and what type of infrastructure and setup that really entails.
Jon Purow:
Got it. So look, all of us came from somewhere before the cannabis industry being the age that it is. So I’m curious to know, out of all the experiences that you went through, skills that you built up prior to the cannabis industry, which did you think has been most instrumental or useful in your leadership role at Harris Supply?
Bryan Gerber:
So I’m one of the fortunate ones that never had a career before this industry. I graduated to university and then went straight into the startup world. But I can tell you persistence and tenacity.
Jon Purow:
Yes. As a parent of girls, I read all my self-improvement articles. They always say that if there’s going to be a determination of success and or happiness, persistence, stick to itness is what you want to roll with so much, right. If at first you don’t succeed, try again. Or if at first you don’t succeed, get high again. Right. There’s got to be some pop pun option that we could come to, so. Got it. So you are one of the lucky few that was born straight into this industry professionally and we’re able to kind of succeed with it. So now being a leader and in the lofty perch, the pop perch that you’ve reached, what advice would you give to other leaders in the cannabis industry? What tips would you put out there?
Bryan Gerber:
Yeah, so in terms of startup world culture, I think the bootstrapping and cash management is a major topic and something that I think a lot of startups that I invest in or do angel investing in, I just preach all day. Cash is king. Focus on managing the cash, lower the burn as fast as possible and try to get to cashflow positive. I think that’s definitely one of the biggest ones because it’s necessary to keep alive and keep the lights on. And I think a lot of people in our industry thought that it was going to kind of be big tech where we can raise unlimited funds and keep going and burn this guy to rob Paul, to pay Peter to pay Sally to that type of thing. So I think that’s definitely a big thing. And I think a lot of other things that I say revolve around finding revenue streams.
Go figure it out. I think a lot of new industries, there’s a lot of rocks that go unturned, and I say turnover every rock because you never know what pot of gold might be under that. And I think for us as horror supply kind of morphing from the paraphernalia, smoking accessories world to getting into this massive pre-roll solutions partner behemoth company, it really showed that we started in one lane and then figured out many more revenue streams to keep the business growing. And I think now looking back, hindsight bias, obviously 2020, I think to really build a big business, you need multiple revenue streams.
Jon Purow:
So look, you stick in a lane, but I think flexibility and also as you said, the vision to expand as you are growing, to continue having money coming in the door. Yeah. I found it funny the way that you were saying cash is king. People might forget that, and there’s plenty of attrition in the industry that we see all the time in terms of people who forget fundamental items like that.
Bryan Gerber:
Yes. I get surprised every day hearing a new story about took money, bought a Ferrari, bought an apartment. I’m like, why can’t I be like that?
Jon Purow:
Well, you could be like that now because you’ve earned the right to be right, but not, it’s not necessarily a requirement. Ferrari, I would say for most startup companies if I’m correct, since I’m just on the service industry side of it. But yeah, I don’t think it’s a requirement.
Bryan Gerber:
Exactly.
Jon Purow:
Yeah, I always have little things pop in my brain. By the way, here’s a slogan for you. We supply what gets you high. There you go. Boom. All right. That’s a freebie for you. I’m sure you have something like that. Now in your time in the industry, what would you say that I always like to focus on? What are some of the biggest surprises at this point? It’s not surprising, as you said, when you hear stories about wonderful ways that people have crashed and burned outside the industry. But what are some of the biggest surprises to you from where you
Bryan Gerber:
Sit? Yeah, for sure. I think one of the biggest surprises, not just from poor leadership that I see in the industry, but the turnover is insane. I mean, the roles get replaced every other week, especially on our side of the business development. You’re sitting there for 90 days going through custom sampling, tooling, all different types of stuff, and you get to the finish line where we’re about to go put the order in and that person gets fired and you’re like, oh no. Okay, now I got it. And then Sally picks it up and she’s like, I have no idea why we’re even here today. I’m like, well, we were working with Joey for nine months and Joey’s no longer there. So Sally, you’re here picking up the pieces. Let me kind of break it down for you. So I think turnover has been one of the biggest pain in the butts in this industry and surprises, another surprise is just how much people can raise and spend in a very short amount of time.
It’s quite intriguing, I guess I’ve seen it. We do a lot of the big MSOs, we deal with a lot of the processors, and I think just some of these guys are able to just continuously raise funds and keep raising and it’s like, where’s the light at the end of the tunnel? For us, we raised three and a half million dollars back in 2018, 2019, and we’ve been cashflow positive since. And so for us it’s a different kind of story of where we didn’t go out and raise tens of millions of dollars, hundreds of millions of dollars. So I think that’s another one is doing a lot with a little bit. And a lot of people seem to have a lot and can’t figure out how to do a little you. But I would say those are probably the two biggest surprises that I’ve come across in this industry.
Jon Purow:
Are there processes that you put into place to streamline having to deal with someone new outside of forwarding the old email chain? Is there anything you’ve done to get accustomed to the fact that there is such frequent turnover?
Bryan Gerber:
I’ve really tried nurturing C-suite relationships so that regardless who ends up becoming the buyer or the supply chain person I’m friendly with, the person at the top
Jon Purow:
Has seemed to. And I think that that touches upon something. There is something in my mind completely unique about how collegial the cannabis industry is, and I’ve always tried to put my finger on it. And I don’t know if it comes all the way back to the puff puff past mentality that sharing is ingrained as part of the culture, but I’m curious to know if you agree, right, and how important relationships can be in this industry.
Bryan Gerber:
Yeah, no, I think this goes back to my early days of being an entrepreneur where everyone’s like, oh, I need you to sign an NDA to talk to you, or if I give you my idea, then you’re just going to steal it from here. And I realized if you sit in a room by yourself telling yourself your own ideas, it never helps anyone or yourself. And so this industry specifically, I feel like when you get into a C-suite room, people are talking about what’s working, what’s not working, what have you guys tried, whatever else. But I think a lot of that core initial gray market guys are still very close to the chest. They don’t share resources or secrets or whatever it is. But I think a lot of the companies that we sit with where we’re like, they’re like, well, we want to implement automation. And we say, well, great, we know Festus, we know pre-roll or we know accelerant, we know all these guys. Here’s all the offerings, here’s all the information. Do with what you will. I’m not here to make the decision for you, but I can offer optionality. And so I think that’s been a lot of the side where, to your point, the pup past. But I think it’s the specific rooms are willing to communicate, but I don’t think it’s the whole market is ready to open up the Komodo and say, this is how we do it.
Jon Purow:
Yeah, I like to say there’s a difference between the can tenderers and the pret pretenders. And to a certain extent, I feel like people who are newer to the industry don’t understand that collegiality exists and are therefore more skeptical. And some of these folks that are coming in from the illicit market, they’re used to being cloak and dagger can a cloak and dagger in the illicit market. And so it’s a process before they realize that they can open up and there are things that happen, but I think in general there’s just something unique about this industry in terms of that. By the way, how much do you, so first off, as I always like to say, my favorite pop pun being a Jewish guy Mar Wof on having one raise and then being able to just continuously expand to where you are. Do you think that that’s a function of being the pick axis in the industry versus plant touching when it comes down to it that partially played how that played out?
Bryan Gerber:
So I think on first off, why raise more money than you need? You’re just going to dilute yourself. And so that’s 1 0 1 for founders, but at this point, we’re the original founders still own majority equity. We control the board, we’re fully autonomous. We basically get to wake up and work with our best friends every day. So it’s a different setup than I think a lot of people get themselves into, which is a loan to own set up with a lot of these companies and they don’t realize what they’re signing on or they’re signing away. And when one thing goes wrong, we’re coming in, you’re out and we’re going to restructure this thing. For us, we feel like we’re the experts, we know how to drive the ship properly. And I feel like if I got replaced or my other co-founders got replaced, I don’t even know if the company would survive.
So for us, I think on the picks and shovels side, of course I’d love to see a he pre-roll on the shelf one day. But for us, I realized that the customers are the MSOs. It’s an input play. If you’re selling them cones, okay, let’s go to tubes next, let’s go to Blunts, let’s go to glass tip cones, whatever the input is, it’s really just create a great service, have great customer service, deliver time and time again, people will keep coming back. And there’s been so many, getting back to that, finding revenue opportunities is a lot of our customers come to us and say, Hey, you guys did so great with this, can you do this? And we figure out how to do it for them. And so I think a lot of people are just tired of getting burned and the turnover and dealing with multiple different supply chain sources and not really having a centralized location or someone they can actually trust that can deliver. Because before us, I’ll give you an example, Jeter Dream Fields, their first orders with us were like 10,000 cones. You see the volume Jeter does today. And so it’s nurturing the customer whether they’re at the start or the end, and we can come in no matter what part of the journey you’re on, and really fix issues or solidify that infrastructure and get you exactly what you need when you need it.
Jon Purow:
Got it. So now one thing that you touched upon is that you are also, in terms of another hat that you wear, a high hat, oh man, I got to restrain it. The pop puns are just always trying to spill out, but you’re also the CEO and founder of Howard Brands and you referenced Hemper. So if you could just give us a little bit of an intro to that, I think that might be helpful for the audience
Bryan Gerber:
For sure. So I’ll do long story short. So company started in 2015 originally on the smoking accessory side, which we started a brand called Hemper, which was a direct to consumer subscription box, kind of like Dollar Shave Club for stoners.
And we morphed that into kind of this celebrity curated box where it was like smoke like Snoop Dogg for a month, about a year and a half doing that. We kind got away from the celebrities and started moving more into our own proprietary themed and we realized that the subscription box was our Trojan horse marketing outlet for developing new smoking accessories. And so what we figured out was that this was our paid test market for us to go design, develop, and implement new products that made your ritual better. And so Hemper has now become an international brand. We’re sold in about 55 countries. We’ve serviced over 2 million customers in the last decade. We’ve got one of the largest social media followings and we’ve got over 500 different products that we’ve developed. And so with Hemper, a lot of the new initiatives for growth have been getting smoking accessories into convenience stores.
So like Mass Market seven 11, circle K, we’ve been doing a lot of international shows. I was telling you before we were at the Mary Jane Berlin, which ended up being like 50,000 consumers and B2B, B2C focused folks from Germany and all the surrounding countries. And so there’s a lot going on internationally. Germany went legal, we’re going to Czech Republic for another show here in a couple months, which they’re probably going to be the next country to go more fully legal. And so I think that domino effect has really rebirth Europe, I think not just, oh, look at what’s going on in North America. It’s legal here. I think now Europe is starting that domino effect for where we kind of picked up a lot of steam over the last five years.
Jon Purow:
Yeah, I mean as I like to say, you have a trailblazer in each geographic region, which is unfortunately why one reason what’s happening in Thailand is where they legalize and then exploded and they’re pulling back is something that I feel is almost like I say, like a golden nugget, not getting enough attention that it could be, that’s not something that’s really happened in the industry before.
Bryan Gerber:
I dunno if you saw today or yesterday the prime Minister got kicked out.
Jon Purow:
Well, no. So thank you for breaking news. I live in my cannabis bubble and I had not checked my podcast news aggregator so hot off the presses whenever we release this interview. I mean, I actually no lukewarm off the presses to possibly a little bit cooler off the presses, but interesting. I did not see that. So that could be an interesting change in the winds there.
Bryan Gerber:
We have a lot of customers in Thailand and they basically told us that now that he’s, so he got kicked out for fraud or something, so now, and he was the one opposing all the cannabis laws, and so now they think it’s going to go back to normal or even be more prolific. And so a lot of our customers, there’re actually ordering now so that in Anticip they’ll have it on hand.
Jon Purow:
Got it. That’s very, very cool. The thing, the overarching thing for me is I feel like ultimately convenience wins. I feel like it’s how Amazon won and I feel like we see as the different sectors looking at the data, how things grow, things like pre-rolls and everything. Do you feel that convenience wins out in cannabis? And that’s, I mean look, you talk about convenience in terms of people being able to come to you at any time and get what they want and to also even when that includes innovation. But I’m curious to know your thoughts about trends towards convenience and how you guys cater to that.
Bryan Gerber:
Yeah, definitely. So on the convenience side, obviously just taking apart the pre-roll category, I think it’s 10 to 15% here roughly. It’s roughly closer to 20% in Canada. And I think what, just taking from the tobacco cigarette industry, that is the most convenient method for consuming tobacco. I think the pre-roll segment is developing at a rapid pace now than previous. It was. I think that’s from a lot more automation in play, availability of cones and providers like myself, our supply, more solutions, partner approaches as well. I think a lot of these companies are trying to get away from the monkey see monkey do act and try and come out their own unique innovative products. And our pitch is really, Hey, let us help you figure out what your Coca-Cola is. We know you don’t know what it is yet, but we’ll walk down the path with you.
And so I think on the convenience factor, the rise of multi-packs is kind of the new 30 rack when we were in college or high school. It’s like I want to go hang out with my buddies. I’m bringing 14 joints with me. It’s all in one pack and I don’t have to figure out who’s smoking what. Everyone gets their own. And especially post covid era, that’s what’s been happening a lot more. Point two five, 0.35 gram joints, you show up with 5, 10, 15 of them and all your buddies get to smoke their own. And I think the micro consumption methods are becoming way more prevalent now. And I think that whole can of curious world is definitely exponentially increasing. So I think the people that want 0.15 or 10 times a day are now coming out more because of the availability of the products. And the people that want to smoke one gram once a day aren’t really the customer anymore. And so now we’re appealing to obviously GTI one of our large clients, they’ve got the dog walkers brand, which is very popular. And I think that’s kind of what the future is for consumption and convenience is really just these, what is the 10 pack, what is the 14 pack? So I can interchange strains, but the mode and the medium is still that microdose joint.
Jon Purow:
I think that raises an interesting question. So we’re talking about, so it’s interesting, right? There are certainly when we talk about the kind of curious, there are folks who are going to put their foot down and they’re never going to smoke or anything like that. However, that begins to shift. And it’s interesting, we’re talking about the puff puff pass mentality and in a post covid world, there’s a movement, something like that, that everyone gets their individualized thing. And the joint experience, pun always intended is that everyone’s sitting having their own joint. And so as you’re saying, the counter curious could get a little bit more open to smoking when what they’re smoking is getting smaller and smaller. And it’s also funny because when you’re passing around something that’s big, you’re only having a certain little amount, but it’s very, very different when you’re actually just holding something tinier psychologically that people who wouldn’t necessarily smoke previously might be open to doing. So when they see, oh, I’m not going to get that messed up, it’s only this little thing I’m in control entirely of how much I’m smoking of it.
Bryan Gerber:
And I think another factor is just the taste and flavor profile of a smaller pre-roll, right? You’re getting better flavor. Most of the hits to get to the finish line are fresh hits. When you’re smoking a one gram joint, you’re smoking this thing, but by 25% of the way through it kind of just tastes like shit. And a lot of people want to move on and I get why. Right? So the rise of this multi-pack micro dose 0.25, I’ve seen all the way down to 1.5 gram joint. We do a brand called Piners up in Canada, tiniest, it’s more paper than cannabis.
Jon Purow:
The podcast proud to be sponsored by Ebos. If you’re in the cannabis business, that quality packaging isn’t just important. It’s essential. That’s where Ebos comes in, whether you’re just starting out or scaling up. Ebos offers proprietary top of the line packaging products built for cannabis. Ebos is the market leader for a good reason. They’re experts in the field, six patents, five warehouse locations around the country and a network of exceptional distributors. So get ebos and grow boldly. Got it. I just came up with bitty blunts, right? There’s a mini blunt brand name right there that we could throw out there. So I’m also curious to know in terms of the innovation that you’re seeing are people, and we have the for the curious, there’s catering and other product categories that ties to effects based. Are you seeing different things in terms of what’s being mixed in terms of effects based and that’s another place of innovation or not necessarily as much?
Bryan Gerber:
Yeah, no. On the pre-roll side for innovation, I would say connoisseur fused market really has taken off over the last few years. I think people realize that adding in a little bit of whether it’s water hash rosin, I’m not the fan of Keith, whatever it is, really does pack that punch, right? And I think for the consumer that’s looking for more of a higher THC level that does get that across for them when they’d have to smoke two or three regular joints to really get the same feeling. And then I think another trend that’s been coming up is more premium. So ceramic filter tips on it, glass filter tips, wood filter tips, those types of things, which we’ve been really dishing out to a lot of companies recently. And also on the not tobacco alternative, but a hemp blunt as well. So we do a product for Eazy called the Eazy forties, which is like a glass tip hemp blunt, and people love it. It smokes awesome. The glass tip is a really elevated experience and to ceramic and glass, the touch is cool. So as you’re smoking it actually feels cooler than it is smoking a regular joint with a paper filter tip.
Jon Purow:
Yes, having experienced it firsthand is completely different and better my opinion in terms of that aspect of it. So that’s I think a great insight. Are there other types of innovation that you’re seeing in other categories that you touch upon in anything? So by the way, just to be clear in terms of the premium that you’re saying that comes down to the plant that’s going into it, that this what a limited release kind of vibe of a specific strain is what you’re referring to with that one.
Bryan Gerber:
I think as consistently growing cannabis, the same strain all the time is very difficult. I know it doesn’t exist actually. Exactly. So I think that a lot of companies are trying to get that across where I can have my cookie strain all the time. It’s the same levels, it’s the same. TURP profiles doesn’t really exist. So I think a lot of these brands, and this could just be kind of a marking ploy. When I was living in California, Lowell Farms used to do these limited edition packs and my business partner would be like, dude, that’s just excess inventory that they put into a multi-pack that’s not limited edition. They didn’t have enough cannabis to fill all these packs as this one strain. So they did a multi-strain box. And I’m thinking as the consumer, wow, this is really cool. I get one strain times 10, I get 10 different strains in this box, that’s really cool.
And I’m basically drinking the Kool-Aid on the marketing. And so you don’t really know whether it was purposeful or they were fixing a problem or things like that. But in terms of innovation, I think in other categories, I think really fast onset edibles are really important because I think the time delay one confuses consumer. I don’t know how to operate whether can I get out of my chair yet or is the ride about a start? And so I think the two milligram or the five milligram little mince or whatever, I think 1907 or 19 33, 1 of those companies does it pretty well.
Jon Purow:
1906,
Bryan Gerber:
Yeah, 1906. Yeah. And so that I think is really important because I think people get overdosed on edibles really quickly and they don’t realize the onsets coming and they don’t know when. So I think,
Yeah, so n emulsification, all that type of stuff is really important and I think that’s why people go towards edibles. And the more microdose side is because it’s more controllable. And I know that I’m not going to get obliterated today, but in terms of bulk flour, I mean there’s not much innovation besides crazy looking bags on vape carts. I think that’s still very much a repurposed market. I don’t think anyone has really developed new technology that really takes it to the next level. I saw recently a company came out with a disposable rosin device where you can put maybe 0.25 of rosin in it. But I was looking at the device and as a rozen user myself, I was like, okay, if I reheat that pen twice, I’m smoking poop like dirt basically, right? Terpenes are burnt off by then I’m not getting any flavor and it kind of tastes like shit. So I think a lot of the innovation has still escaped this market, but I think a lot of the nerdy science cannabis guys are figuring out if we tweak this, we can get a better plan and maybe better genetics or we can get rid of some of the bad parts of this plan through tissue cultures and that type of innovation. But I think in terms of the end product, people are still trying to figure it out,
Jon Purow:
Agree. And I do respect the good marketing thing and no matter how it’s motivated, he said as he took his sip out of a Stanley Cup that one of his daughters bought rather than a construction worker. There we go. Actually, I want to go back to the innovation thing because I was impressed by something you said that a lot of people are focused on it or having their own, I guess, customized, right? I’m curious to know in terms of the folks that are looking for those, and you said Hemper was this amazing almost market research tool, you’re up to offering 500 different products. Is there a demographic that you see the people who want customization or the people who want innovation? Is it the big folks? Is it the brand new folks trying to establish a foothold that are actually thinking ahead? I’m curious to know how that breaks down.
Bryan Gerber:
So from an MSO perspective, I think they’re just trying to get the wheels turning in a consistent manner. I don’t think they’re trying to complicate their business any more than it already is. So when we pitch innovation on the pre-roll side to them, they kind of don’t know what to do with it yet. And I’d have to fight really hard to get this across the table. When you look at more of those SSO operators that are going into more of the key strategic markets that are brand focused, they’re the ones that are looking for the innovation, right? Because I think those are owned by more of the heady owners or kind of the old school cannabis 1.0 guys. And I think that they’re the ones looking for the innovation. I think the MSOs are just looking to create a quality product that’s really consistent and it’s on the shelf all the time, which is kind of the Walmart method and guys like Jeter and Sneezy and those brands are really truly looking for the innovation. And I think that’s what’s going to keep the social proof aspects of them being more popular than another MSO brand is that kind of grassroots like, oh, we’re developing new stuff or we got these new strain flavors or new terpene profiles or whatever it is. So I think those are the guys that are looking for it. I think the are really just looking to stay consistent, have product available and fix all their issues.
Jon Purow:
Yeah, no, and I think that that makes sense because there’s so many brands there. Everyone is trying to be the national brands, arguably only one has crossed over at this point. And so if you’re competing in this kind of stoner slaughterhouse of brands, innovation is one path. Marketing is another path to differentiating yourself. So it makes sense, as you said, right? They’re not trying to be the Walmart, they’re trying to stick out and last. So I think that that makes a lot of sense. Now, I always like to geek out, I’m trying to be the Dan historic, the most ganja geek that, and I always like to ask my interviewees who have access to different types of data, what are surprises that you see in the data? What are trends that you are seeing that you’re comfortable sharing from your position in the industry?
Bryan Gerber:
One thing that continuously surprises me is how much distillate cartridges are sold in this country. I don’t know who’s using them. I mean I know who’s using them, but I mean it’s like poop soup and a cartridge. And there’s companies that are doing 2, 3, 4, 500 million a year selling distillate in carts or vapes or whatever. And I just don’t understand it. I don’t think consumers really understand it, what they’re smoking. And even in markets like Nevada where we’re using remediation tactics to get rid of microbials and heavy metals and all this stuff, and we’re reintroducing it back into the market in edibles and carts and cards and it’s like something doesn’t sound all right here, but yeah, one of the biggest ones is how much distillate product is sold in this country.
Jon Purow:
Sorry, I didn’t mean to interrupt, but I agree with you. It’s when you’re dealing with the end consumer, we speak this language so well, having been in it so long that everything just becomes secondhand. And yet when interacting with people out there and trying to tell them about the difference between hemp products and state licensed products, they have no idea. The question I get more than anything for consumers is why can I buy that in a gas station? And it just shows that there’s this level of not knowing that is surprising. And I just think that that’s a function of familiarity to a certain extent. The people like us who are constantly dealing with this, and it’s like the same thing where you’re talking and you use acronyms with an assumption that people are going to understand and there’s that base level of standing that sometimes isn’t there. Not to say that we were doing that at all in this conversation, but it’s just an example of how you literally start speaking a specific language with baseline knowledge. And it’s crazy when you see that people are just, the major consumers out there are not anywhere near that level of understanding
Bryan Gerber:
The whole trend that’s been going on in our country about don’t use seed oils anymore. That’s basically distillate people
Jon Purow:
We’re pulling back the layer. We just did a maram Uck raking thing, right? Brian’s news flash, right? So all consumers out there,
Bryan Gerber:
And I think to your point about the D eight stuff that’s going on, I think that’s a big conversation that I was having at Benzinga about six months ago was the dispensaries. I don’t know if they even realize if they don’t have their merchandising proper, they don’t have product on the shelves, they’re losing the sale to the smoke shop around the corner or the gas station around the corner where I can get my snack, my $5 delta, I can get my $5 cart from there, I can get my drinks and I can get all my accessories. And I think that MSOs are losing a lot of business to these gas station, the hemp market, hemp drive market, but I don’t think consumers really realize what they’re even inhaling or consuming. I think the FDA has done a shit job at figuring out how to really regulate this and stop this and the DA and the A TF and all these guys that are claiming they’re pulling stuff off the shelves.
I really don’t think they are. And I think it’s just kind of like, well, it’s kind of happening so we can’t enforce it. We don’t have enough manpower. But it’s like you probably do, but you choose not to. And I think a lot of these companies, when I’m pitching merchandising programs to MSOs and they’re like, well, it’s not really a focus. I’m like, well, is it losing more business to the guy around the corner that’s selling the D eight, the smoke shop and the snack at the same time? Because to convince a dispensary chain why seven 11 has a Slurpee machine and why they have cups and straws is a hard conversation to get through.
Jon Purow:
I never forget, one of the pieces of law school that I go back to the most is it’s not one thing to just make the law. It’s another thing to enforce it. And I mean frankly, look at the, I think it comes down to a certain extent, like a variation on degree. The fact that cannabis doesn’t kill people comes in very handy when the DEA has to make a choice. Fentanyl enforcement and enforcement against some of these cannabinoids. I remember the Delta eight joint F-D-A-C-D-C thing. What did they say? 646 people went to the hospital and then they were fine. And so I think that that almost plays to our advantage. But this is also in your role here. I mean, you’re selling picks and shovels to state license and hemp folks, right? I mean you have hemper, right? And so you get to occupy a position where there’s no choosing size or anything. You’re catering to whatever vehicle it is that people are getting and you actually have an insight into the relative size of the markets. Also is one interesting point I would say with where you are occupying the industry.
Bryan Gerber:
Definitely. Yeah. No, we see it going to a champs trade show. If you look at the show floor, I mean there’s so many D eight hemp derived THCA brands, you would think that it was legal and normal and totally cool. Yeah, and I think what’s really shitty is now I guess they’re finding with the whole amanita gummies and all these crazy gummy product or mushroom products that it’s actually like synthetic DMT and all these crazy other synthetic drugs and it’s just like what is going on? What happened to just smoking good old fashioned cannabis
Jon Purow:
The way that you delivered that line sounded a little bit esque. That was even like, I appreciated that for some reason it almost got draw and it rose above for that reason for me had to say that. So look, as a success story in terms of expanding from the three co-founders to now over 2000 employees, what are the next steps that you see in terms of growing the company, right? I mean we talked about expanding into different product lines. What are that or regions? I mean you touched upon, where do you see growth coming in the next couple steps?
Bryan Gerber:
Definitely. So one of our big initiatives has been getting the reliance of this industry off of China and moving things outside of that. So we’ve been investing heavily in India and the infrastructure that we have over there. And so we’ve been pulling, obviously we did cones out of there, we’re doing glass out of there now. We just started our own injection mold facilities. So we’re actually doing packaging now out of India. And so definitely getting away from the tariff issues and all those extra expenses that a lot of the packaging companies put on the customers nowadays, you don’t get that working with us because we’re pulling it out of a different country. So definitely that. And I think in terms of the domestic market merchandising and helping figure out these dispensary chains, how to successfully bring accessories in and sell them to your customers, I think people need to realize that your customer that’s coming to buy their eighth for the week does not care about a t-shirt or a lanyard anymore.
It just doesn’t work. It hasn’t worked. It never worked. It isn’t going to work. And everyone’s focused on, oh, well it’s only 1% of our total top line revenue. Well, it’s like a self-fulfilling prophecy. If you don’t focus on it, it’s going to stay at 1%. And so I think showing them that it can be 5% of your total top line and here’s your path to that and we’re going to help in terms of distribution and making sure all the shelter stocked and here’s your merchandising program, here’s your planogram. Here’s all these things that traditional retailers focus on that we just somehow can’t figure out in this industry. So helping them figure that part out. And then definitely international, right? That’s been massive for us in terms of just getting out there. Like I said, we were in Germany, we were in Spain for cannabis. I mean, it’s so ingrained in the culture there. It’s just a matter of time where once it goes fully legal, it’s already there. It’s the infrastructure, the farms, everything is already there. It’s really just like can the governments and the parliament and all these prime ministers get their act together and realize it’s the undertones been there, just let’s bring it out.
Jon Purow:
Yeah. There’s no issue like this where say in the US you have 70% support. And when you see the polls in Europe, like Italy, very, very conservative country in certain respects, the polls are crazy in terms of being in favor of it. And yet crossing the finish line becomes so difficult because of what I’m still calling though. I don’t love the pop pun marijuana, no betters, right? That it’s just there’s that puritanical roots that whether it’s from the Pope himself or whatever it is in Italy, that it’s just like it’s difficult. We a universe, we need a worldwide ballot initiative, is what I think we need, is that the people in the world can be like, Hey, governments of the world, 70% of us are down for this. This drug is less harmful than alcohol. Why don’t we try it? So I always like to wrap up by the way, but I never can decide what I want to call it. So please, I do want your vote. Right. So now Brian, I want you to be either Toker dus or smoker Domus and let us know which one you like. You are putting on your wizard hat in the stylized like a joint, right? Throw out anything that you foresee on a macro micro level on a near far term basis for the industry. Just throw out some thoughts.
Bryan Gerber:
I have to pick whether I’m toker, dus, or smoker.
Jon Purow:
That’s the most important part of the question. I’m kidding
Bryan Gerber:
With Tous. And in terms of foresee in terms of macro, micro level, good question.
Jon Purow:
Just anything it pops in your brain box.
Bryan Gerber:
I think everyone is fooling themselves on phal legalization and the timeline. I keep saying this time and time again, there is no way federal government can play friendly with the states by increasing more taxes.
Jon Purow:
Do you think that the progress that’s made on the hemp side is like a form of stealth federal legalization? I mean we have hemp D nine beverages being sold in major alcohol chains at this point.
Bryan Gerber:
I know everyone’s pissed off at total wine. I think it’s letting the big boys play in the gray. I don’t think it’s doing much.
Jon Purow:
It doesn’t actually push us forward. You’re saying because it’s just, it’s risk appetite that people are wandering out there when we realize at any point, hey, the next farm bill could come along and all that could be put back in the bottle with potentially good reason considering the lack of regulation and some of these cannabinoids. So I think that’s your take on that. Yes. Okay. Any quick closing thoughts? I don’t want to run over too much and infringe on your time and you’ve been so giving with it.
Bryan Gerber:
If you need to contact us for any reason, our supply, we’re the premier solutions partner for the pre-roll category. We’re here to help whether we do it or not.
Jon Purow:
Alright. They’ll do it if they can. Exactly. That’s how they got to where they are. So look, Brian, I just want to say I thought that that was fascinating and I really, really appreciate your taking the time. Thank you so much, sir, for joining.
Bryan Gerber:
Thank you, John. Appreciate you having me on today.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
You may like
-
Appellate Court Rules Delta-8, Delta-10 THC Prohibited in Maryland
-
Laws, public perception lagging risk, expert says
-
Federal Marijuana Legalization Bill Deserves Lawmakers’ Support, Letter From ACLU And Other Groups Says
-
Watertown could create new rules for cannabis shops
-
Rhode Island Opens Applications for 24 Adult-Use Dispensary Licenses
-
Kentucky still waiting on medical marijuana dispensaries 9 months after law passed
featured
Appellate Court Rules Delta-8, Delta-10 THC Prohibited in Maryland

Published
54 minutes agoon
September 15, 2025
Delta-8 and delta-10 THC are illegal, and state law that prohibits businesses from selling hemp-derived products without a license is constitutional, the Appellate Court of Maryland ruled on Sept. 9.
The ruling reverses a lower court’s decision to grant a preliminary injunction to the Maryland Hemp Coalition and several hemp retailers, producers, farmers and consumers, who had challenged the state’s licensing requirement under the Cannabis Reform Act (CRA) that the Maryland General Assembly passed in 2023 to regulate an adult-use marketplace.
The now-lifted injunction had prevented state officials from enforcing the CRA’s licensing requirement for hemp-related businesses wishing to sell intoxicating products.
Although the state is now allowed to enforce the licensing requirements on hemp businesses, the Maryland Appellate Court ruled that intoxicating products containing synthetic hemp derivatives created in a chemical process remain illegal.
“While this case turns on the state’s ability to enforce the licensing requirement against hemp-derived psychoactive products, the parties have not addressed the legality of these products,” Appellate Judge Daniel A. Friedman wrote. “As we explain below, hemp-derived psychoactive products, so-called delta-8 and delta-10 THC, are now and have always been illegal in Maryland. That the prohibition has been the subject of lax enforcement does not make it legal.”
Furthermore, the judge pointed out that intoxicating products with hemp derivatives took off nationwide after the 2018 Farm Bill federally legalized the commercial cultivation of hemp because U.S. lawmakers did not regulate finished goods in that agricultural legislation.
“This may have contributed to businesses in Maryland and across the country selling these products,” Friedman wrote.
However, the judge explained, the 2018 Farm Bill did not prevent state governments from regulating their hemp marketplaces more stringently than the federal legislation. And, since the Maryland Department of Agriculture submitted Maryland’s state hemp plan to the U.S. Department of Agriculture in 2020, the 2018 Farm Bill does not preempt the state’s regulations on hemp, the court ruled.
The Maryland General Assembly adopted the state’s hemp cultivation program in 2019 and placed restrictions on intoxicating hemp-derived products.
“Based on the regulatory history of hemp and the products derived from it, the legal status of hemp-derived psychoactive products in Maryland prior to the enactment of the Cannabis Reform Act was clear,” Friedman wrote. “While these products may have proliferated during the period of regulatory uncertainty created by the 2018 federal Farm Bill, Maryland law prohibited the use or creation of hemp-derived psychoactive products.
“Significantly, the Cannabis Reform Act bans the sale of most hemp-derived psychoactive products. It does so by prohibiting products ‘not derived from naturally occurring biologically active chemical constituents.’ AB § 36-1102(c). Thus, because hemp-derived psychoactive products, including delta-8 and delta-10 THC, are derived from a chemical process … these products are prohibited.”
The Maryland Hemp Coalition, et al., also argued in the lawsuit that the CRA created an unconstitutional monopoly under Article 41 of the Maryland Declaration of Rights because of a common right exception. Maryland was the first state to adopt a constitutional anti-monopoly provision in 1776, according to the appellate court.
The court considered whether there was a common right to intoxicating hemp-derived products in both the broader cannabis market and the limited hemp market. The court determined there was not a common right in the broader market because of cannabis’s Schedule I federal status under the Controlled Substances Act. The court also determined Maryland’s agricultural hemp laws did not create a common right.
Under the monopoly argument, the court ruled Maryland Hemp Coalition did not attempt to define the relative market—including the size of the market, the products involved, and the size of the monopoly in relation to the market—which Friedman opined was a relevant matter of law.
The court considered several choices for a relevant market:
- All intoxicating products (hemp, marijuana, alcohol, other drugs)
- All products of the cannabis plant (hemp, marijuana, nonintoxicating, intoxicating, intended for human consumption, not intended for consumption)
- Only intoxicating cannabis products (hemp, marijuana)
- Only marijuana products
- Only hemp products
“The determination of the relevant market is neither theoretical nor academic,” Friedman wrote. “It affects whether a litigant can prove their Article 41 claims, it affects the type of analysis a court performs, and it affects whether an alleged monopoly satisfies an exception under Article 41. … In fact, we think the failure to identify the relevant market led to confusion here. That is, the Hemp Coalition’s arguments could apply to at least two markets—the broader cannabis market or the limited hemp-derived psychoactive products market.”
Given the ambiguity, the court ruled the Maryland Hemp Coalition cannot succeed on its monopoly argument that the CRA infringes on a common right.
Furthermore, the court determined that the CRA is permissible under Article 41 because the state’s cannabis regulations are “reasonably required” for the public interests, including consumer safety, youth protections, and social equity initiatives that remedy past discrimination.
“The Maryland General Assembly considered the dangers of both cannabis products generally and hemp-derived psychoactive products specifically and, in response, created a licensing requirement alongside product safety standards under the Cannabis Reform Act,” Friedman wrote. “We hold that the licensing requirement was reasonably required to protect the public health and fits within the public interest exception to Article 41.”
As a result of the court ruling, all Maryland businesses must first obtain a cannabis license before selling any intoxicating cannabinoid products—whether derived from marijuana or hemp.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
Federal Marijuana Legalization Bill Deserves Lawmakers’ Support, Letter From ACLU And Other Groups Says

Published
3 hours agoon
September 15, 2025
A coalition of drug policy reform and civil rights organizations sent letter urging members of the U.S. House of Representatives to cosponsor a recently filed bill to federally legalize marijuana and promote equity.
The letter, led by the Drug Policy Alliance (DPA), expresses support for the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, which was reintroduced by Rep. Jerrold Nadler (D-NY) and about three dozen cosponsors late last month.
This marks the fourth session in a row that Nadler has put forward the proposal. It passed the House twice under Democratic control while the sponsor served as chairman of the Judiciary Committee, but it did not advance last session with Republicans in the majority.
“The MORE Act is the leading comprehensive marijuana reform bill in the House that ends federal prohibition, addresses the collateral consequences of federal marijuana criminalization, and takes steps to ensure the regulated marketplace is diverse and inclusive,” the letter—which was also signed by groups such as the ACLU, National Association of Criminal Defense Lawyers, National Association of Social Workers, Service Employees International Union and Southern Poverty Law Center—says.
“For generations, marijuana’s placement on the [Controlled Substances Act, or CSA] has disproportionately inflicted harm upon communities of color and poor people,” the groups wrote.
They noted that the Trump administration is actively considering a proposal to simply reschedule cannabis, which they described as “a policy that would continue federal cannabis criminalization and its harm.”
With that reform pending, it’s “more important than ever for Congress to advance comprehensive legislation to deschedule marijuana from the CSA,” the letter says. “To be clear, as long as marijuana remains anywhere in the CSA, it will still be criminalized at the federal level.”
“Recent news reports have suggested that President Trump may move marijuana to Schedule III of the CSA. While this move would eliminate an unfair tax penalty on the marijuana industry and would be of symbolic importance by recognizing that marijuana has accepted medical use, little else would change. In fact, rescheduling marijuana from Schedule I to Schedule III of CSA will maintain the criminal penalties and collateral consequences that are in effect today. To fully address the conflict between state and federal laws, marijuana must be descheduled from the CSA.”
Other signatories on the letter include Cannabis Regulators of Color Coalition (CRCC), Doctors for Drug Policy Reform, JustLeadershipUSA, Last Prisoner Project (LPP), Law Enforcement Action Partnership (LEAP), Lawyers’ Committee for Civil Rights Under Law, Minority Cannabis Business Association (MCBA), Mission Green, NORML, Students for Sensible Drug Policy (SSDP), Supernova Women and more.
Here are details about the key provisions of the MORE Act:
- The bill would deschedule marijuana by removing it from the list of federally banned drugs under the CSA. However, it would not require states to legalize cannabis and would maintain a level of regulatory discretion up to states.
- Marijuana products would be subject to a federal excise tax, starting at five percent for the first two years after enactment and rising to eight percent by the fifth year of implementation.
- Nobody could be denied federal public benefits based solely on the use or possession of marijuana or past juvenile conviction for a cannabis offense. Federal agencies couldn’t use “past or present cannabis or marijuana use as criteria for granting, denying, or rescinding a security clearance.”
- Noncitizens could not be penalized under federal immigration laws for certain cannabis activity after the enactment of the legislation.
- The bill creates a process for expungements of non-violent federal marijuana convictions.
- Tax revenue from cannabis sales would be placed in a new “Opportunity Trust Fund.” Half of those tax dollars would support a “Community Reinvestment Grant Program” under the Justice Department, 10 percent would support substance misuse treatment programs, 40 percent would go to the federal Small Business Administration (SBA) to support implementation and a newly created equitable licensing grant program.
- The Community Reinvestment Grant Program would “fund eligible non-profit community organizations to provide a variety of services for individuals adversely impacted by the War on Drugs…to include job training, reentry services, legal aid for civil and criminal cases (including for expungement of cannabis convictions), among others.”
- The program would further support funding for substance misuse treatment for people from communities disproportionately impacted by drug criminalization. Those funds would be available for programs offering services to people with substance misuse disorders for any drug, not just cannabis.
- While the bill wouldn’t force states to adopt legalization, it would create incentives to promote equity. For example, SBA would facilitate a program to providing licensing grants to states and localities that have moved to expunge records for people with prior marijuana convictions or “taken steps to eliminate violations or other penalties for persons still under State or local criminal supervision for a cannabis-related offense or violation for conduct now lawful under State or local law.”
- The bill’s proposed Cannabis Restorative Opportunity Program would provide funds “for loans to assist small business concerns that are owned and controlled by individuals adversely impacted by the War on Drugs in eligible States and localities.”
- The comptroller general, in consultation with the head of the U.S. Department of Health and Human Services (HHS), would be required to carry out a study on the demographics of people who have faced federal marijuana convictions, “including information about the age, race, ethnicity, sex, and gender identity.”
- The departments of treasury, justice and the SBA would need to “issue or amend any rules, standard operating procedures, and other legal or policy guidance necessary to carry out implementation of the MORE Act” within one year of its enactment.
- Marijuana producers and importers would also need to obtain a federal permit. And they would be subject to a $1,000 per year federal tax as well for each premise they operate.
- The bill would impose certain packaging and labeling requirements.
- It also prescribes penalties for unlawful conduct such as illegal, unlicensed production or importation of cannabis products.
- The Treasury secretary would be required to carry out a study “on the characteristics of the cannabis industry, with recommendations to improve the regulation of the industry and related taxes.”
- The Bureau of Labor Statistics (BLS) would be required to “regularly compile, maintain, and make public data on the demographics” of marijuana business owners and workers.
- Workers in “safety sensitive” positions, such as those regulated by the Department of Transportation, could continue to be drug tested for THC and face penalties for unauthorized use. Federal workers would also continue to be subject to existing drug testing policies.
- References to “marijuana” or “marihuana” under federal statute would be changed to “cannabis.” It’s unclear if that would also apply to the title of the bill itself.
Getting a bill like the MORE Act through the GOP-controlled House and Senate is a tall task, however. And while Trump previously endorsed a Florida legalization ballot initiative, he’s given little indication he’d be willing to end prohibition altogether at the federal level.
A pending proposal to simply move cannabis from Schedule I to Schedule III under the CSA is still in flux—though the president did recently say a decision was imminent.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
Numerous voices within Trump’s circles have expressed differing opinions on the reform.
Most recently, for example, Ben Carson, Trump’s former secretary of the Department of Housing and Urban Development (HUD), said a move to reschedule marijuana would play into plots to “destroy this country.”
Trump’s former press secretary Sean Spicer and his long-time advisor Roger Stone recently traded diverging takes on the prospect of the administration moving forward on marijuana rescheduling.
Stone separately made the case for reform in an op-ed for Marijuana Moment last month.
Retired boxer Mike Tyson, meanwhile, recently spoke about the need for federal marijuana rescheduling on a podcast hosted by the wife of White House Deputy Chief of Staff for Policy Stephen Miller—saying he’s expecting “good news” on the issue soon.
In June, the retired boxer also took to Fox News and delivered a message to the president, urging him to reschedule, and ultimately legalize, marijuana.
That interview came days after Tyson led a letter alongside other professional athletes and celebrities promoting cannabis reform that was sent to Trump, calling for rescheduling marijuana, expanding clemency and allowing licensed cannabis businesses to access the banking system.
Meanwhile, Trump’s former senior advisor Kellyanne Conway has been the “biggest champion” of marijuana rescheduling within the president’s “inner circle,” a GOP congressman recently told Marijuana Moment.
Photo courtesy of Brian Shamblen.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
Rhode Island Opens Applications for 24 Adult-Use Dispensary Licenses

Published
4 hours agoon
September 15, 2025
[PRESS RELEASE] – WARWICK, R.I., Sept. 12, 2025 – The Cannabis Control Commission (CCC) opened the application period for adult-use cannabis retail licenses, marking the beginning of the largest expansion to Rhode Island’s cannabis industry. The commission is authorized under the Rhode Island Cannabis Act to license up to 24 retail establishments statewide, divided equally across six geographic zones, making this announcement a defining moment in shaping the state’s cannabis marketplace.
“Today’s announcement represents years of work, collaboration and preparation to ensure Rhode Island has a cannabis marketplace that is safe, transparent, and equitable,” CCC Chairperson Kim Ahern said. “The release of this application and launch of our submission portal is not only about opening doors for businesses but about creating meaningful opportunities for Rhode Islanders while keeping public health and public safety at the center of everything we do.”
With only 24 retail licenses available statewide, the launch of the application process is expected to draw significant interest from prospective applicants. Together with the Social Equity Applicant Status Certification Portal, which opened in August, the application process reflects the CCC’s deliberate steps toward building a cannabis industry that prioritizes economic opportunity, equity and fairness in Rhode Island.
“Rhode Island’s cannabis market is poised for growth, and this application is helping us do exactly that,” Gov. Dan McKee said. “As we expand the cannabis industry here in the Ocean State, we’re opening the doors to new investment, new good-paying jobs, and new opportunities for our economy.”
Adult-use retail licenses will authorize sales of cannabis products to adults 21 and older. By releasing the application and opening the submission portal simultaneously, the commission is providing applicants with a transparent process while reinforcing its commitment to accountability and access.
“Today’s release of the adult-use retail license application reflects the commission’s commitment to equity and accountability,” Commissioner Layi Oduyingbo said. “This framework provides applicants with the information they need while reinforcing our responsibility to safeguard public health and consumer safety.”
Commissioner Robert Jacquard said, “The commission aims to make this application process as business-friendly as possible, while upholding standards that will protect public health.”
To ensure the process is fair and accessible, the commission and Cannabis Office will provide technical assistance resources and ongoing guidance for prospective applicants. Applications will be accepted until 4 p.m. on Dec. 29, 2025.
“This is a milestone that reflects the dedication and perseverance of so many people,” Cannabis Office Administrator Michelle Reddish said. “From lawmakers and advocates to community members and our dedicated staff, countless individuals have helped build the foundation for this moment. By publishing the application today, we are taking a historic step toward building a cannabis marketplace that serves consumers, supports equity and advances public health in Rhode Island.”
The adult-use retail license application is available on the commission’s website at www.ccc.ri.gov/auapp.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.

Appellate Court Rules Delta-8, Delta-10 THC Prohibited in Maryland

Laws, public perception lagging risk, expert says

Federal Marijuana Legalization Bill Deserves Lawmakers’ Support, Letter From ACLU And Other Groups Says

Watertown could create new rules for cannabis shops

Rhode Island Opens Applications for 24 Adult-Use Dispensary Licenses

Kentucky still waiting on medical marijuana dispensaries 9 months after law passed

Can LSD Battle Anxiety? The Answer Is Yes, According to Science

Six hurt in shooting at marijuana event in SF's Bayview

Kentucky Medical Marijuana Dispensaries Should Be Stocked With Products Ready For Sale By Next Month, Top State Official Says

Deputies: 3,500 child sex abuse images, marijuana grow operation found in NC home raid

Regulators Ready to Enforce Cannabis Laws on Hemp THC Retailers in Maryland

California reaps over $250 million from 2nd Quarter cannabis sales

Meet the World’s First Cannabis Rugby Team: Crewmen 7’s Tackle Stigma Head-On

Texas Supreme Court Refuses To Take Up Marijuana Case Challenging State’s Rejection Of Local Decriminalization Law

California Passes Bill to Ban Intoxicating Hemp Products Outside Cannabis Market

Pending Federal Hemp Legislation Could Reshape The Legal Industry By Banning Some Products (Op-Ed)

Verano Proposes to Redomicile Parent Company From British Columbia to Nevada

8,000 cannabis plants seized from illegal Bradford grow-op

New York Lawmakers Schedule Psychedelics-Focused Hearing To Discuss ‘Medicinal Value And Risks’ Of Psilocybin

Curaleaf Opens Cannabis Dispensaries in Florida, Ohio

How to Protect Your Outdoor Cannabis Crops From Pests

Feds provide anti-cannabis group a platform to bash legalization (Newsletter: September 15, 2025)

Dozen arrested after south Mississippi bust for illegal sales to underage customers

The Toking Traveler: Why Amsterdam Weed Is Mostly Boof

Alert: Department of Cannabis Control updates data dashboards with full data for 2023

Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!

5 best CBD creams of 2024 by Leafly

EU initiative begins bid to open access to psychedelic therapies

New Study Analyzes the Effects of THCV, CBD on Weight Loss

Free delta-9 gummies from Bay Smokes

Discover New York’s dankest cannabis brands [September 2024]

5 best autoflower seed banks of 2024 by Leafly

Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

May 2024 Leafly HighLight: Pink Runtz strain

Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT

Recreational cannabis on ballot for third time in South Dakota

5 best THC drinks of 2024 by Leafly

Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News

Mississippi city official pleads guilty to selling fake CBD products

6 best CBD gummies of 2024 by Leafly

Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”

The Daily Hit: October 2, 2024

5 best delta-9 THC gummies of 2024 by Leafly

Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline

PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana

5 best THCA flower of 2024 by Leafly

People In This State Googled ‘Medical Marijuana’ The Most, Study Shows
Trending
-
California Cannabis Updates1 year ago
Alert: Department of Cannabis Control updates data dashboards with full data for 2023
-
Breaking News1 year ago
Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
-
best list1 year ago
5 best CBD creams of 2024 by Leafly
-
Business12 months ago
EU initiative begins bid to open access to psychedelic therapies
-
cbd1 year ago
New Study Analyzes the Effects of THCV, CBD on Weight Loss
-
Bay Smokes1 year ago
Free delta-9 gummies from Bay Smokes
-
cannabis brands12 months ago
Discover New York’s dankest cannabis brands [September 2024]
-
autoflower seeds12 months ago
5 best autoflower seed banks of 2024 by Leafly